Verition Fund Management »

Neumora Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $303k 22k 13.75

More positions owned by Verition Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
salesforce Call Option (CRM)
Apple Call Option (AAPL)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Ishares Msci Brazil Etf Put Option (EWZ)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Goldman Sachs (GS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Sea Note 2.375%12/0 (Principal)

View all positions for Verition Fund Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
FMR
MIC Capital Management UK
T. Rowe Price Investment Management
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Johnson & Johnson
Citadel Advisors
Avidity Partners Management
Hillhouse Capital Advisors
OrbiMed Advisors
BlackRock
Soros Capital Management

View all funds holding Neumora Therapeutics